nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—PTGS2—pancreatic cancer	0.122	1	CbGaD
Dexamethasone—NOS2—Doxorubicin—pancreatic cancer	0.0542	0.0858	CbGbCtD
Dexamethasone—ABCB11—Tamoxifen—pancreatic cancer	0.0308	0.0488	CbGbCtD
Dexamethasone—CYP1B1—Tamoxifen—pancreatic cancer	0.0308	0.0488	CbGbCtD
Dexamethasone—CYP1B1—Erlotinib—pancreatic cancer	0.0262	0.0415	CbGbCtD
Dexamethasone—CYP19A1—Tamoxifen—pancreatic cancer	0.025	0.0396	CbGbCtD
Dexamethasone—CYP1B1—Docetaxel—pancreatic cancer	0.0173	0.0275	CbGbCtD
Dexamethasone—CYP1A1—Dacarbazine—pancreatic cancer	0.017	0.0269	CbGbCtD
Dexamethasone—ABCC2—Tamoxifen—pancreatic cancer	0.0162	0.0257	CbGbCtD
Dexamethasone—CYP2A6—Tamoxifen—pancreatic cancer	0.0158	0.0251	CbGbCtD
Dexamethasone—ABCG2—Tamoxifen—pancreatic cancer	0.0146	0.0232	CbGbCtD
Dexamethasone—CYP1A1—Tamoxifen—pancreatic cancer	0.0135	0.0214	CbGbCtD
Dexamethasone—CYP2E1—Dacarbazine—pancreatic cancer	0.0131	0.0208	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—pancreatic cancer	0.0129	0.0205	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—pancreatic cancer	0.0129	0.0205	CbGbCtD
Dexamethasone—ABCG2—Erlotinib—pancreatic cancer	0.0125	0.0197	CbGbCtD
Dexamethasone—ABCC2—Irinotecan—pancreatic cancer	0.0124	0.0197	CbGbCtD
Dexamethasone—CYP2A6—Fluorouracil—pancreatic cancer	0.0117	0.0185	CbGbCtD
Dexamethasone—CYP1A1—Erlotinib—pancreatic cancer	0.0115	0.0182	CbGbCtD
Dexamethasone—ABCG2—Irinotecan—pancreatic cancer	0.0112	0.0178	CbGbCtD
Dexamethasone—CYP3A7—Tamoxifen—pancreatic cancer	0.0108	0.0171	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0108	0.0171	CbGbCtD
Dexamethasone—ABCG2—Fluorouracil—pancreatic cancer	0.0108	0.0171	CbGbCtD
Dexamethasone—CYP2E1—Tamoxifen—pancreatic cancer	0.0104	0.0165	CbGbCtD
Dexamethasone—CYP2B6—Tamoxifen—pancreatic cancer	0.0103	0.0163	CbGbCtD
Dexamethasone—ABCB11—bile duct—pancreatic cancer	0.00939	0.216	CbGeAlD
Dexamethasone—ABCC2—Docetaxel—pancreatic cancer	0.00911	0.0144	CbGbCtD
Dexamethasone—ABCC2—Sunitinib—pancreatic cancer	0.00907	0.0144	CbGbCtD
Dexamethasone—CYP3A7—Irinotecan—pancreatic cancer	0.0083	0.0132	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0083	0.0132	CbGbCtD
Dexamethasone—ABCG2—Docetaxel—pancreatic cancer	0.00824	0.0131	CbGbCtD
Dexamethasone—ABCG2—Sunitinib—pancreatic cancer	0.0082	0.013	CbGbCtD
Dexamethasone—CYP3A5—Tamoxifen—pancreatic cancer	0.00811	0.0129	CbGbCtD
Dexamethasone—CYP2B6—Irinotecan—pancreatic cancer	0.00791	0.0125	CbGbCtD
Dexamethasone—CYP2C8—Tamoxifen—pancreatic cancer	0.0078	0.0124	CbGbCtD
Dexamethasone—ABCB11—bile—pancreatic cancer	0.00722	0.166	CbGeAlD
Dexamethasone—CYP3A5—Erlotinib—pancreatic cancer	0.0069	0.0109	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—pancreatic cancer	0.00679	0.0108	CbGbCtD
Dexamethasone—CYP2C8—Erlotinib—pancreatic cancer	0.00663	0.0105	CbGbCtD
Dexamethasone—CYP2C19—Tamoxifen—pancreatic cancer	0.00654	0.0104	CbGbCtD
Dexamethasone—CYP3A5—Irinotecan—pancreatic cancer	0.00623	0.00987	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—pancreatic cancer	0.00614	0.00973	CbGbCtD
Dexamethasone—CYP3A7—Docetaxel—pancreatic cancer	0.00609	0.00964	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.00609	0.00964	CbGbCtD
Dexamethasone—CYP3A7—Sunitinib—pancreatic cancer	0.00606	0.0096	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00606	0.0096	CbGbCtD
Dexamethasone—CYP2C8—Fluorouracil—pancreatic cancer	0.00575	0.00911	CbGbCtD
Dexamethasone—CYP2C9—Tamoxifen—pancreatic cancer	0.00544	0.00862	CbGbCtD
Dexamethasone—ABCB1—Tamoxifen—pancreatic cancer	0.00528	0.00837	CbGbCtD
Dexamethasone—CYP2D6—Tamoxifen—pancreatic cancer	0.00498	0.00788	CbGbCtD
Dexamethasone—ABCC2—bile duct—pancreatic cancer	0.00478	0.11	CbGeAlD
Dexamethasone—CYP3A5—Docetaxel—pancreatic cancer	0.00457	0.00723	CbGbCtD
Dexamethasone—ABCB1—Gemcitabine—pancreatic cancer	0.00455	0.00721	CbGbCtD
Dexamethasone—CYP3A5—Sunitinib—pancreatic cancer	0.00454	0.0072	CbGbCtD
Dexamethasone—ABCB1—Erlotinib—pancreatic cancer	0.00449	0.00711	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—pancreatic cancer	0.00432	0.00685	CbGbCtD
Dexamethasone—CYP2D6—Erlotinib—pancreatic cancer	0.00423	0.0067	CbGbCtD
Dexamethasone—ABCB1—Irinotecan—pancreatic cancer	0.00405	0.00642	CbGbCtD
Dexamethasone—CYP2C9—Fluorouracil—pancreatic cancer	0.00401	0.00635	CbGbCtD
Dexamethasone—ABCC2—bile—pancreatic cancer	0.00367	0.0843	CbGeAlD
Dexamethasone—CYP3A4—Tamoxifen—pancreatic cancer	0.00316	0.00501	CbGbCtD
Dexamethasone—ABCB1—Docetaxel—pancreatic cancer	0.00297	0.00471	CbGbCtD
Dexamethasone—ABCB1—Sunitinib—pancreatic cancer	0.00296	0.00469	CbGbCtD
Dexamethasone—CYP3A4—Erlotinib—pancreatic cancer	0.00269	0.00426	CbGbCtD
Dexamethasone—CYP3A4—Irinotecan—pancreatic cancer	0.00243	0.00385	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—pancreatic cancer	0.00221	0.00351	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—pancreatic cancer	0.00209	0.00331	CbGbCtD
Dexamethasone—ANXA1—gall bladder—pancreatic cancer	0.00197	0.0452	CbGeAlD
Dexamethasone—CYP3A4—Docetaxel—pancreatic cancer	0.00178	0.00282	CbGbCtD
Dexamethasone—CYP3A4—Sunitinib—pancreatic cancer	0.00177	0.00281	CbGbCtD
Dexamethasone—PLA2G1B—islet of Langerhans—pancreatic cancer	0.00169	0.0388	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—pancreatic cancer	0.00133	0.0021	CbGbCtD
Dexamethasone—ANXA1—islet of Langerhans—pancreatic cancer	0.00129	0.0297	CbGeAlD
Dexamethasone—CYP4A11—digestive system—pancreatic cancer	0.00122	0.0281	CbGeAlD
Dexamethasone—PLA2G1B—pancreas—pancreatic cancer	0.00119	0.0273	CbGeAlD
Dexamethasone—PLA2G1B—digestive system—pancreatic cancer	0.00101	0.0233	CbGeAlD
Dexamethasone—ANXA1—pancreas—pancreatic cancer	0.000908	0.0208	CbGeAlD
Dexamethasone—ABCB11—digestive system—pancreatic cancer	0.000788	0.0181	CbGeAlD
Dexamethasone—ANXA1—digestive system—pancreatic cancer	0.000775	0.0178	CbGeAlD
Dexamethasone—PTGS2—gall bladder—pancreatic cancer	0.000592	0.0136	CbGeAlD
Dexamethasone—NR3C2—digestive system—pancreatic cancer	0.000502	0.0115	CbGeAlD
Dexamethasone—CYP3A5—islet of Langerhans—pancreatic cancer	0.000452	0.0104	CbGeAlD
Dexamethasone—NR3C1—islet of Langerhans—pancreatic cancer	0.000449	0.0103	CbGeAlD
Dexamethasone—SLCO1A2—digestive system—pancreatic cancer	0.00043	0.00988	CbGeAlD
Dexamethasone—ABCC2—digestive system—pancreatic cancer	0.000401	0.0092	CbGeAlD
Dexamethasone—CYP1B1—digestive system—pancreatic cancer	0.000393	0.00901	CbGeAlD
Dexamethasone—PTGS2—islet of Langerhans—pancreatic cancer	0.000388	0.00891	CbGeAlD
Dexamethasone—CYP2C19—digestive system—pancreatic cancer	0.000344	0.00791	CbGeAlD
Dexamethasone—CYP3A5—pancreas—pancreatic cancer	0.000318	0.0073	CbGeAlD
Dexamethasone—NR3C1—pancreas—pancreatic cancer	0.000315	0.00724	CbGeAlD
Dexamethasone—CYP1A1—digestive system—pancreatic cancer	0.000278	0.00637	CbGeAlD
Dexamethasone—PTGS2—pancreas—pancreatic cancer	0.000273	0.00627	CbGeAlD
Dexamethasone—CYP3A5—digestive system—pancreatic cancer	0.000271	0.00623	CbGeAlD
Dexamethasone—CYP2B6—digestive system—pancreatic cancer	0.00027	0.00619	CbGeAlD
Dexamethasone—NR3C1—digestive system—pancreatic cancer	0.000269	0.00618	CbGeAlD
Dexamethasone—CYP2C9—digestive system—pancreatic cancer	0.000267	0.00613	CbGeAlD
Dexamethasone—CYP2E1—digestive system—pancreatic cancer	0.000253	0.00581	CbGeAlD
Dexamethasone—ABCB1—islet of Langerhans—pancreatic cancer	0.00024	0.00551	CbGeAlD
Dexamethasone—PTGS2—digestive system—pancreatic cancer	0.000233	0.00535	CbGeAlD
Dexamethasone—CYP3A4—digestive system—pancreatic cancer	0.000204	0.00468	CbGeAlD
Dexamethasone—CYP2D6—digestive system—pancreatic cancer	0.0002	0.0046	CbGeAlD
Dexamethasone—ABCB1—pancreas—pancreatic cancer	0.000169	0.00388	CbGeAlD
Dexamethasone—ABCB1—digestive system—pancreatic cancer	0.000144	0.00331	CbGeAlD
Dexamethasone—Increased appetite—Doxorubicin—pancreatic cancer	0.000107	0.000859	CcSEcCtD
Dexamethasone—Migraine—Epirubicin—pancreatic cancer	0.000107	0.000858	CcSEcCtD
Dexamethasone—Affect lability—Epirubicin—pancreatic cancer	0.000107	0.000858	CcSEcCtD
Dexamethasone—Anorexia—Gemcitabine—pancreatic cancer	0.000107	0.000854	CcSEcCtD
Dexamethasone—Dizziness—Erlotinib—pancreatic cancer	0.000107	0.000853	CcSEcCtD
Dexamethasone—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000106	0.000844	CcSEcCtD
Dexamethasone—Anorexia—Fluorouracil—pancreatic cancer	0.000105	0.000839	CcSEcCtD
Dexamethasone—Hypotension—Gemcitabine—pancreatic cancer	0.000105	0.000837	CcSEcCtD
Dexamethasone—Eye disorder—Docetaxel—pancreatic cancer	0.000105	0.000836	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000104	0.000834	CcSEcCtD
Dexamethasone—Insomnia—Irinotecan—pancreatic cancer	0.000104	0.000832	CcSEcCtD
Dexamethasone—Cardiac arrest—Epirubicin—pancreatic cancer	0.000104	0.000829	CcSEcCtD
Dexamethasone—Vomiting—Tamoxifen—pancreatic cancer	0.000104	0.000829	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—pancreatic cancer	0.000103	0.000827	CcSEcCtD
Dexamethasone—Mood swings—Epirubicin—pancreatic cancer	0.000103	0.000826	CcSEcCtD
Dexamethasone—Paraesthesia—Irinotecan—pancreatic cancer	0.000103	0.000826	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—pancreatic cancer	0.000103	0.000824	CcSEcCtD
Dexamethasone—Hypotension—Fluorouracil—pancreatic cancer	0.000103	0.000823	CcSEcCtD
Dexamethasone—Rash—Tamoxifen—pancreatic cancer	0.000103	0.000822	CcSEcCtD
Dexamethasone—Dermatitis—Tamoxifen—pancreatic cancer	0.000103	0.000821	CcSEcCtD
Dexamethasone—Vomiting—Erlotinib—pancreatic cancer	0.000103	0.00082	CcSEcCtD
Dexamethasone—Headache—Tamoxifen—pancreatic cancer	0.000102	0.000816	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000102	0.000816	CcSEcCtD
Dexamethasone—Rash—Erlotinib—pancreatic cancer	0.000102	0.000813	CcSEcCtD
Dexamethasone—Dermatitis—Erlotinib—pancreatic cancer	0.000102	0.000812	CcSEcCtD
Dexamethasone—Angiopathy—Docetaxel—pancreatic cancer	0.000102	0.000812	CcSEcCtD
Dexamethasone—Insomnia—Gemcitabine—pancreatic cancer	0.000101	0.00081	CcSEcCtD
Dexamethasone—Dyspepsia—Irinotecan—pancreatic cancer	0.000101	0.000809	CcSEcCtD
Dexamethasone—Headache—Erlotinib—pancreatic cancer	0.000101	0.000808	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000101	0.000807	CcSEcCtD
Dexamethasone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000101	0.000804	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.0001	0.000802	CcSEcCtD
Dexamethasone—Asthenia—Sunitinib—pancreatic cancer	0.0001	0.000801	CcSEcCtD
Dexamethasone—Dry skin—Epirubicin—pancreatic cancer	0.0001	0.000799	CcSEcCtD
Dexamethasone—Decreased appetite—Irinotecan—pancreatic cancer	0.0001	0.000799	CcSEcCtD
Dexamethasone—Arrhythmia—Docetaxel—pancreatic cancer	9.99e-05	0.000799	CcSEcCtD
Dexamethasone—Insomnia—Fluorouracil—pancreatic cancer	9.96e-05	0.000796	CcSEcCtD
Dexamethasone—Migraine—Doxorubicin—pancreatic cancer	9.93e-05	0.000794	CcSEcCtD
Dexamethasone—Affect lability—Doxorubicin—pancreatic cancer	9.93e-05	0.000794	CcSEcCtD
Dexamethasone—Hypokalaemia—Epirubicin—pancreatic cancer	9.93e-05	0.000794	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	9.93e-05	0.000794	CcSEcCtD
Dexamethasone—Fatigue—Irinotecan—pancreatic cancer	9.91e-05	0.000793	CcSEcCtD
Dexamethasone—Paraesthesia—Fluorouracil—pancreatic cancer	9.89e-05	0.000791	CcSEcCtD
Dexamethasone—Alopecia—Docetaxel—pancreatic cancer	9.89e-05	0.00079	CcSEcCtD
Dexamethasone—Pruritus—Sunitinib—pancreatic cancer	9.88e-05	0.00079	CcSEcCtD
Dexamethasone—Pain—Irinotecan—pancreatic cancer	9.83e-05	0.000786	CcSEcCtD
Dexamethasone—Erythema—Docetaxel—pancreatic cancer	9.74e-05	0.000779	CcSEcCtD
Dexamethasone—Decreased appetite—Gemcitabine—pancreatic cancer	9.74e-05	0.000779	CcSEcCtD
Dexamethasone—Dyspepsia—Fluorouracil—pancreatic cancer	9.69e-05	0.000775	CcSEcCtD
Dexamethasone—Nausea—Tamoxifen—pancreatic cancer	9.68e-05	0.000774	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	9.67e-05	0.000773	CcSEcCtD
Dexamethasone—Fatigue—Gemcitabine—pancreatic cancer	9.66e-05	0.000772	CcSEcCtD
Dexamethasone—Muscular weakness—Epirubicin—pancreatic cancer	9.62e-05	0.000769	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—pancreatic cancer	9.6e-05	0.000767	CcSEcCtD
Dexamethasone—Pain—Gemcitabine—pancreatic cancer	9.58e-05	0.000766	CcSEcCtD
Dexamethasone—Nausea—Erlotinib—pancreatic cancer	9.58e-05	0.000766	CcSEcCtD
Dexamethasone—Decreased appetite—Fluorouracil—pancreatic cancer	9.57e-05	0.000765	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—pancreatic cancer	9.56e-05	0.000764	CcSEcCtD
Dexamethasone—Diarrhoea—Sunitinib—pancreatic cancer	9.55e-05	0.000764	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	9.51e-05	0.00076	CcSEcCtD
Dexamethasone—Feeling abnormal—Irinotecan—pancreatic cancer	9.48e-05	0.000758	CcSEcCtD
Dexamethasone—Pain—Fluorouracil—pancreatic cancer	9.42e-05	0.000753	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Irinotecan—pancreatic cancer	9.4e-05	0.000752	CcSEcCtD
Dexamethasone—Dry skin—Doxorubicin—pancreatic cancer	9.25e-05	0.00074	CcSEcCtD
Dexamethasone—Dizziness—Sunitinib—pancreatic cancer	9.23e-05	0.000738	CcSEcCtD
Dexamethasone—Feeling abnormal—Gemcitabine—pancreatic cancer	9.23e-05	0.000738	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—pancreatic cancer	9.19e-05	0.000734	CcSEcCtD
Dexamethasone—Body temperature increased—Irinotecan—pancreatic cancer	9.09e-05	0.000727	CcSEcCtD
Dexamethasone—Abdominal pain—Irinotecan—pancreatic cancer	9.09e-05	0.000727	CcSEcCtD
Dexamethasone—Feeling abnormal—Fluorouracil—pancreatic cancer	9.07e-05	0.000726	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—pancreatic cancer	8.9e-05	0.000712	CcSEcCtD
Dexamethasone—Vomiting—Sunitinib—pancreatic cancer	8.88e-05	0.00071	CcSEcCtD
Dexamethasone—Body temperature increased—Gemcitabine—pancreatic cancer	8.85e-05	0.000708	CcSEcCtD
Dexamethasone—Rash—Sunitinib—pancreatic cancer	8.8e-05	0.000704	CcSEcCtD
Dexamethasone—Dermatitis—Sunitinib—pancreatic cancer	8.79e-05	0.000703	CcSEcCtD
Dexamethasone—Urticaria—Fluorouracil—pancreatic cancer	8.75e-05	0.0007	CcSEcCtD
Dexamethasone—Headache—Sunitinib—pancreatic cancer	8.74e-05	0.000699	CcSEcCtD
Dexamethasone—Syncope—Docetaxel—pancreatic cancer	8.73e-05	0.000698	CcSEcCtD
Dexamethasone—Body temperature increased—Fluorouracil—pancreatic cancer	8.71e-05	0.000696	CcSEcCtD
Dexamethasone—Weight increased—Epirubicin—pancreatic cancer	8.58e-05	0.000686	CcSEcCtD
Dexamethasone—Loss of consciousness—Docetaxel—pancreatic cancer	8.56e-05	0.000684	CcSEcCtD
Dexamethasone—Weight decreased—Epirubicin—pancreatic cancer	8.53e-05	0.000682	CcSEcCtD
Dexamethasone—Hyperglycaemia—Epirubicin—pancreatic cancer	8.5e-05	0.00068	CcSEcCtD
Dexamethasone—Convulsion—Docetaxel—pancreatic cancer	8.44e-05	0.000675	CcSEcCtD
Dexamethasone—Hypertension—Docetaxel—pancreatic cancer	8.41e-05	0.000672	CcSEcCtD
Dexamethasone—Myalgia—Docetaxel—pancreatic cancer	8.29e-05	0.000663	CcSEcCtD
Dexamethasone—Nausea—Sunitinib—pancreatic cancer	8.29e-05	0.000663	CcSEcCtD
Dexamethasone—Asthenia—Irinotecan—pancreatic cancer	8.25e-05	0.00066	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Epirubicin—pancreatic cancer	8.24e-05	0.000659	CcSEcCtD
Dexamethasone—Conjunctivitis—Epirubicin—pancreatic cancer	8.17e-05	0.000653	CcSEcCtD
Dexamethasone—Asthenia—Gemcitabine—pancreatic cancer	8.04e-05	0.000643	CcSEcCtD
Dexamethasone—Oedema—Docetaxel—pancreatic cancer	7.95e-05	0.000636	CcSEcCtD
Dexamethasone—Anaphylactic shock—Docetaxel—pancreatic cancer	7.95e-05	0.000636	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—pancreatic cancer	7.94e-05	0.000635	CcSEcCtD
Dexamethasone—Pruritus—Gemcitabine—pancreatic cancer	7.92e-05	0.000634	CcSEcCtD
Dexamethasone—Infection—Docetaxel—pancreatic cancer	7.9e-05	0.000631	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—pancreatic cancer	7.89e-05	0.000631	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.87e-05	0.000629	CcSEcCtD
Dexamethasone—Diarrhoea—Irinotecan—pancreatic cancer	7.87e-05	0.000629	CcSEcCtD
Dexamethasone—Shock—Docetaxel—pancreatic cancer	7.82e-05	0.000625	CcSEcCtD
Dexamethasone—Nervous system disorder—Docetaxel—pancreatic cancer	7.79e-05	0.000623	CcSEcCtD
Dexamethasone—Pruritus—Fluorouracil—pancreatic cancer	7.79e-05	0.000623	CcSEcCtD
Dexamethasone—Thrombocytopenia—Docetaxel—pancreatic cancer	7.78e-05	0.000622	CcSEcCtD
Dexamethasone—Tachycardia—Docetaxel—pancreatic cancer	7.76e-05	0.00062	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—pancreatic cancer	7.68e-05	0.000614	CcSEcCtD
Dexamethasone—Diarrhoea—Gemcitabine—pancreatic cancer	7.66e-05	0.000613	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.62e-05	0.00061	CcSEcCtD
Dexamethasone—Dizziness—Irinotecan—pancreatic cancer	7.6e-05	0.000608	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—pancreatic cancer	7.58e-05	0.000606	CcSEcCtD
Dexamethasone—Anorexia—Docetaxel—pancreatic cancer	7.58e-05	0.000606	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—pancreatic cancer	7.56e-05	0.000604	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—pancreatic cancer	7.55e-05	0.000603	CcSEcCtD
Dexamethasone—Diarrhoea—Fluorouracil—pancreatic cancer	7.53e-05	0.000602	CcSEcCtD
Dexamethasone—Hypotension—Docetaxel—pancreatic cancer	7.43e-05	0.000594	CcSEcCtD
Dexamethasone—Vomiting—Irinotecan—pancreatic cancer	7.31e-05	0.000585	CcSEcCtD
Dexamethasone—Dizziness—Fluorouracil—pancreatic cancer	7.28e-05	0.000582	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—pancreatic cancer	7.27e-05	0.000581	CcSEcCtD
Dexamethasone—Rash—Irinotecan—pancreatic cancer	7.25e-05	0.00058	CcSEcCtD
Dexamethasone—Dermatitis—Irinotecan—pancreatic cancer	7.24e-05	0.000579	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.24e-05	0.000579	CcSEcCtD
Dexamethasone—Headache—Irinotecan—pancreatic cancer	7.2e-05	0.000576	CcSEcCtD
Dexamethasone—Insomnia—Docetaxel—pancreatic cancer	7.19e-05	0.000575	CcSEcCtD
Dexamethasone—Paraesthesia—Docetaxel—pancreatic cancer	7.14e-05	0.000571	CcSEcCtD
Dexamethasone—Vomiting—Gemcitabine—pancreatic cancer	7.12e-05	0.000569	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—pancreatic cancer	7.11e-05	0.000568	CcSEcCtD
Dexamethasone—Rash—Gemcitabine—pancreatic cancer	7.06e-05	0.000565	CcSEcCtD
Dexamethasone—Dermatitis—Gemcitabine—pancreatic cancer	7.06e-05	0.000564	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—pancreatic cancer	7.05e-05	0.000564	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—pancreatic cancer	7.02e-05	0.000561	CcSEcCtD
Dexamethasone—Headache—Gemcitabine—pancreatic cancer	7.02e-05	0.000561	CcSEcCtD
Dexamethasone—Vomiting—Fluorouracil—pancreatic cancer	7e-05	0.00056	CcSEcCtD
Dexamethasone—Dyspepsia—Docetaxel—pancreatic cancer	7e-05	0.000559	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—pancreatic cancer	6.98e-05	0.000558	CcSEcCtD
Dexamethasone—Rash—Fluorouracil—pancreatic cancer	6.94e-05	0.000555	CcSEcCtD
Dexamethasone—Dermatitis—Fluorouracil—pancreatic cancer	6.94e-05	0.000555	CcSEcCtD
Dexamethasone—Decreased appetite—Docetaxel—pancreatic cancer	6.91e-05	0.000552	CcSEcCtD
Dexamethasone—Headache—Fluorouracil—pancreatic cancer	6.9e-05	0.000552	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.86e-05	0.000549	CcSEcCtD
Dexamethasone—Fatigue—Docetaxel—pancreatic cancer	6.85e-05	0.000548	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—pancreatic cancer	6.85e-05	0.000547	CcSEcCtD
Dexamethasone—Nausea—Irinotecan—pancreatic cancer	6.83e-05	0.000546	CcSEcCtD
Dexamethasone—Pain—Docetaxel—pancreatic cancer	6.8e-05	0.000543	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—pancreatic cancer	6.74e-05	0.000539	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—pancreatic cancer	6.73e-05	0.000538	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—pancreatic cancer	6.67e-05	0.000533	CcSEcCtD
Dexamethasone—Nausea—Gemcitabine—pancreatic cancer	6.65e-05	0.000532	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—pancreatic cancer	6.57e-05	0.000525	CcSEcCtD
Dexamethasone—Feeling abnormal—Docetaxel—pancreatic cancer	6.55e-05	0.000524	CcSEcCtD
Dexamethasone—Nausea—Fluorouracil—pancreatic cancer	6.54e-05	0.000523	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—pancreatic cancer	6.53e-05	0.000522	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.5e-05	0.00052	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—pancreatic cancer	6.33e-05	0.000507	CcSEcCtD
Dexamethasone—Abdominal pain—Docetaxel—pancreatic cancer	6.28e-05	0.000502	CcSEcCtD
Dexamethasone—Body temperature increased—Docetaxel—pancreatic cancer	6.28e-05	0.000502	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—pancreatic cancer	6.24e-05	0.000499	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—pancreatic cancer	6.17e-05	0.000493	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—pancreatic cancer	6.09e-05	0.000487	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—pancreatic cancer	6.08e-05	0.000486	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—pancreatic cancer	5.92e-05	0.000474	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—pancreatic cancer	5.9e-05	0.000472	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—pancreatic cancer	5.89e-05	0.000471	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—pancreatic cancer	5.77e-05	0.000462	CcSEcCtD
Dexamethasone—Asthenia—Docetaxel—pancreatic cancer	5.7e-05	0.000456	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—pancreatic cancer	5.69e-05	0.000455	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—pancreatic cancer	5.67e-05	0.000453	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.64e-05	0.000451	CcSEcCtD
Dexamethasone—Pruritus—Docetaxel—pancreatic cancer	5.62e-05	0.00045	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—pancreatic cancer	5.59e-05	0.000447	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—pancreatic cancer	5.57e-05	0.000446	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—pancreatic cancer	5.53e-05	0.000442	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—pancreatic cancer	5.48e-05	0.000438	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—pancreatic cancer	5.46e-05	0.000437	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—pancreatic cancer	5.45e-05	0.000436	CcSEcCtD
Dexamethasone—Diarrhoea—Docetaxel—pancreatic cancer	5.44e-05	0.000435	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—pancreatic cancer	5.36e-05	0.000429	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—pancreatic cancer	5.36e-05	0.000429	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—pancreatic cancer	5.34e-05	0.000427	CcSEcCtD
Dexamethasone—Infection—Epirubicin—pancreatic cancer	5.33e-05	0.000426	CcSEcCtD
Dexamethasone—Shock—Epirubicin—pancreatic cancer	5.27e-05	0.000422	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—pancreatic cancer	5.27e-05	0.000421	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—pancreatic cancer	5.26e-05	0.00042	CcSEcCtD
Dexamethasone—Dizziness—Docetaxel—pancreatic cancer	5.26e-05	0.00042	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—pancreatic cancer	5.25e-05	0.00042	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—pancreatic cancer	5.25e-05	0.00042	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—pancreatic cancer	5.23e-05	0.000418	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—pancreatic cancer	5.18e-05	0.000414	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—pancreatic cancer	5.17e-05	0.000414	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—pancreatic cancer	5.16e-05	0.000412	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—pancreatic cancer	5.11e-05	0.000409	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—pancreatic cancer	5.11e-05	0.000409	CcSEcCtD
Dexamethasone—Vomiting—Docetaxel—pancreatic cancer	5.05e-05	0.000404	CcSEcCtD
Dexamethasone—Rash—Docetaxel—pancreatic cancer	5.01e-05	0.000401	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—pancreatic cancer	5.01e-05	0.000401	CcSEcCtD
Dexamethasone—Dermatitis—Docetaxel—pancreatic cancer	5.01e-05	0.0004	CcSEcCtD
Dexamethasone—Headache—Docetaxel—pancreatic cancer	4.98e-05	0.000398	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.96e-05	0.000397	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—pancreatic cancer	4.96e-05	0.000397	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—pancreatic cancer	4.93e-05	0.000394	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.88e-05	0.000391	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—pancreatic cancer	4.88e-05	0.00039	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—pancreatic cancer	4.86e-05	0.000389	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.86e-05	0.000388	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—pancreatic cancer	4.85e-05	0.000388	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—pancreatic cancer	4.84e-05	0.000387	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—pancreatic cancer	4.81e-05	0.000385	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.8e-05	0.000383	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—pancreatic cancer	4.73e-05	0.000378	CcSEcCtD
Dexamethasone—Nausea—Docetaxel—pancreatic cancer	4.72e-05	0.000377	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—pancreatic cancer	4.72e-05	0.000377	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—pancreatic cancer	4.66e-05	0.000373	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—pancreatic cancer	4.64e-05	0.000371	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.63e-05	0.00037	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—pancreatic cancer	4.62e-05	0.00037	CcSEcCtD
Dexamethasone—Pain—Epirubicin—pancreatic cancer	4.58e-05	0.000367	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.52e-05	0.000361	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—pancreatic cancer	4.49e-05	0.000359	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—pancreatic cancer	4.45e-05	0.000356	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—pancreatic cancer	4.42e-05	0.000353	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.38e-05	0.000351	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—pancreatic cancer	4.37e-05	0.000349	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—pancreatic cancer	4.31e-05	0.000345	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.28e-05	0.000342	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—pancreatic cancer	4.28e-05	0.000342	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—pancreatic cancer	4.26e-05	0.000341	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—pancreatic cancer	4.24e-05	0.000339	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—pancreatic cancer	4.24e-05	0.000339	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—pancreatic cancer	4.24e-05	0.000339	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—pancreatic cancer	4.09e-05	0.000327	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.06e-05	0.000324	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—pancreatic cancer	3.94e-05	0.000315	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—pancreatic cancer	3.92e-05	0.000314	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—pancreatic cancer	3.92e-05	0.000314	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—pancreatic cancer	3.85e-05	0.000308	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—pancreatic cancer	3.79e-05	0.000303	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—pancreatic cancer	3.67e-05	0.000293	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—pancreatic cancer	3.56e-05	0.000285	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—pancreatic cancer	3.55e-05	0.000283	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—pancreatic cancer	3.51e-05	0.000281	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—pancreatic cancer	3.41e-05	0.000273	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—pancreatic cancer	3.39e-05	0.000271	CcSEcCtD
Dexamethasone—Rash—Epirubicin—pancreatic cancer	3.38e-05	0.00027	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—pancreatic cancer	3.38e-05	0.00027	CcSEcCtD
Dexamethasone—Headache—Epirubicin—pancreatic cancer	3.36e-05	0.000269	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—pancreatic cancer	3.28e-05	0.000262	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—pancreatic cancer	3.18e-05	0.000255	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—pancreatic cancer	3.15e-05	0.000252	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—pancreatic cancer	3.13e-05	0.00025	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—pancreatic cancer	3.12e-05	0.00025	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—pancreatic cancer	3.11e-05	0.000248	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—pancreatic cancer	2.95e-05	0.000236	CcSEcCtD
Dexamethasone—ABCG2—Metabolism—APOE—pancreatic cancer	5.33e-06	6.85e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PPARG—pancreatic cancer	5.3e-06	6.81e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	5.29e-06	6.79e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—APOE—pancreatic cancer	5.29e-06	6.79e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.27e-06	6.76e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—AKT1—pancreatic cancer	5.27e-06	6.76e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.26e-06	6.76e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CD44—pancreatic cancer	5.25e-06	6.74e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TERT—pancreatic cancer	5.2e-06	6.68e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—STK11—pancreatic cancer	5.16e-06	6.63e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCL8—pancreatic cancer	5.16e-06	6.62e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.14e-06	6.6e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PPARG—pancreatic cancer	5.11e-06	6.56e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.09e-06	6.54e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GCG—pancreatic cancer	5.03e-06	6.46e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—TYMS—pancreatic cancer	5e-06	6.42e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HIF1A—pancreatic cancer	4.98e-06	6.39e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TSC2—pancreatic cancer	4.96e-06	6.37e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CASP3—pancreatic cancer	4.94e-06	6.34e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AKT1—pancreatic cancer	4.89e-06	6.28e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—APOE—pancreatic cancer	4.86e-06	6.24e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—APOE—pancreatic cancer	4.85e-06	6.22e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.84e-06	6.22e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.83e-06	6.21e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	4.83e-06	6.2e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTEN—pancreatic cancer	4.82e-06	6.19e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CG—pancreatic cancer	4.81e-06	6.18e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCND1—pancreatic cancer	4.81e-06	6.17e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—TYMS—pancreatic cancer	4.81e-06	6.17e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.8e-06	6.16e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	4.77e-06	6.13e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	4.76e-06	6.11e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—STK11—pancreatic cancer	4.73e-06	6.07e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—TYMS—pancreatic cancer	4.71e-06	6.04e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—TYMS—pancreatic cancer	4.7e-06	6.03e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CD44—pancreatic cancer	4.68e-06	6.01e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MMP9—pancreatic cancer	4.67e-06	5.99e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	4.66e-06	5.98e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	4.65e-06	5.97e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PPARG—pancreatic cancer	4.65e-06	5.96e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTEN—pancreatic cancer	4.64e-06	5.96e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	4.62e-06	5.93e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PPARG—pancreatic cancer	4.6e-06	5.91e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.59e-06	5.89e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CD44—pancreatic cancer	4.57e-06	5.87e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.55e-06	5.84e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AKT1—pancreatic cancer	4.52e-06	5.8e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GCG—pancreatic cancer	4.49e-06	5.77e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOTCH1—pancreatic cancer	4.48e-06	5.75e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.44e-06	5.7e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—TYMS—pancreatic cancer	4.44e-06	5.7e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GCG—pancreatic cancer	4.38e-06	5.63e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	4.37e-06	5.61e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGF—pancreatic cancer	4.33e-06	5.56e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CD44—pancreatic cancer	4.31e-06	5.53e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SRC—pancreatic cancer	4.3e-06	5.52e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CD44—pancreatic cancer	4.27e-06	5.48e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PIK3CA—pancreatic cancer	4.24e-06	5.44e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CD—pancreatic cancer	4.23e-06	5.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—STK11—pancreatic cancer	4.22e-06	5.42e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PPARG—pancreatic cancer	4.22e-06	5.42e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	4.21e-06	5.4e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	4.19e-06	5.38e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—pancreatic cancer	4.19e-06	5.38e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.18e-06	5.37e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—pancreatic cancer	4.17e-06	5.36e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—pancreatic cancer	4.15e-06	5.33e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.14e-06	5.32e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRAS—pancreatic cancer	4.14e-06	5.31e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GCG—pancreatic cancer	4.13e-06	5.3e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—STK11—pancreatic cancer	4.12e-06	5.29e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—pancreatic cancer	4.11e-06	5.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GCG—pancreatic cancer	4.1e-06	5.26e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—TYMS—pancreatic cancer	4.07e-06	5.22e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—APOE—pancreatic cancer	4.07e-06	5.22e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	4.05e-06	5.2e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTEN—pancreatic cancer	4.03e-06	5.17e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—pancreatic cancer	4.02e-06	5.16e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.96e-06	5.09e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—APOE—pancreatic cancer	3.91e-06	5.02e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.9e-06	5e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—STK11—pancreatic cancer	3.88e-06	4.99e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CA—pancreatic cancer	3.87e-06	4.97e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—pancreatic cancer	3.86e-06	4.95e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CD—pancreatic cancer	3.85e-06	4.95e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—STK11—pancreatic cancer	3.85e-06	4.94e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.85e-06	4.94e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TGFB1—pancreatic cancer	3.85e-06	4.94e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	3.84e-06	4.94e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—pancreatic cancer	3.84e-06	4.92e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.83e-06	4.92e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—APOE—pancreatic cancer	3.83e-06	4.92e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—APOE—pancreatic cancer	3.82e-06	4.91e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—pancreatic cancer	3.77e-06	4.84e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CB—pancreatic cancer	3.69e-06	4.74e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CG—pancreatic cancer	3.67e-06	4.71e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	3.66e-06	4.69e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—pancreatic cancer	3.65e-06	4.69e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.64e-06	4.67e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—pancreatic cancer	3.64e-06	4.67e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TYMS—pancreatic cancer	3.63e-06	4.66e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—pancreatic cancer	3.62e-06	4.65e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.61e-06	4.64e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—APOE—pancreatic cancer	3.61e-06	4.63e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—pancreatic cancer	3.56e-06	4.57e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TYMS—pancreatic cancer	3.55e-06	4.55e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARG—pancreatic cancer	3.54e-06	4.55e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	3.53e-06	4.53e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—pancreatic cancer	3.5e-06	4.5e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—pancreatic cancer	3.46e-06	4.44e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	3.46e-06	4.44e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	3.45e-06	4.43e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—pancreatic cancer	3.43e-06	4.4e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.42e-06	4.39e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARG—pancreatic cancer	3.41e-06	4.37e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—pancreatic cancer	3.4e-06	4.37e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CB—pancreatic cancer	3.36e-06	4.31e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	3.35e-06	4.3e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.34e-06	4.29e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARG—pancreatic cancer	3.34e-06	4.28e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARG—pancreatic cancer	3.33e-06	4.27e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—pancreatic cancer	3.32e-06	4.26e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.31e-06	4.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—APOE—pancreatic cancer	3.31e-06	4.25e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	3.27e-06	4.2e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	3.26e-06	4.18e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CD—pancreatic cancer	3.23e-06	4.14e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—pancreatic cancer	3.19e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—pancreatic cancer	3.17e-06	4.07e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—pancreatic cancer	3.16e-06	4.06e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—pancreatic cancer	3.16e-06	4.06e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARG—pancreatic cancer	3.14e-06	4.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.13e-06	4.02e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—pancreatic cancer	3.13e-06	4.02e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	3.1e-06	3.98e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	3.04e-06	3.9e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	3.03e-06	3.89e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—pancreatic cancer	3.03e-06	3.89e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.99e-06	3.83e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—pancreatic cancer	2.98e-06	3.82e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—APOE—pancreatic cancer	2.95e-06	3.79e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—pancreatic cancer	2.9e-06	3.73e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—pancreatic cancer	2.9e-06	3.72e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—APOE—pancreatic cancer	2.88e-06	3.7e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.88e-06	3.7e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	2.86e-06	3.68e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	2.84e-06	3.65e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CD44—pancreatic cancer	2.82e-06	3.62e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CB—pancreatic cancer	2.81e-06	3.61e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.8e-06	3.59e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—pancreatic cancer	2.78e-06	3.57e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—APOE—pancreatic cancer	2.72e-06	3.49e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	2.7e-06	3.47e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GCG—pancreatic cancer	2.7e-06	3.47e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—APOE—pancreatic cancer	2.69e-06	3.46e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SRC—pancreatic cancer	2.69e-06	3.46e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—pancreatic cancer	2.68e-06	3.44e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—pancreatic cancer	2.67e-06	3.43e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.67e-06	3.42e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	2.65e-06	3.4e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	2.64e-06	3.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.63e-06	3.37e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—pancreatic cancer	2.62e-06	3.37e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—pancreatic cancer	2.62e-06	3.36e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.6e-06	3.34e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—pancreatic cancer	2.6e-06	3.33e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—pancreatic cancer	2.59e-06	3.32e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.57e-06	3.3e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	2.57e-06	3.29e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.55e-06	3.27e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—STK11—pancreatic cancer	2.54e-06	3.26e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARG—pancreatic cancer	2.51e-06	3.22e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	2.5e-06	3.21e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—pancreatic cancer	2.47e-06	3.18e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	2.47e-06	3.17e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.45e-06	3.15e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.43e-06	3.12e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—pancreatic cancer	2.43e-06	3.12e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—pancreatic cancer	2.41e-06	3.1e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFB1—pancreatic cancer	2.41e-06	3.09e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—pancreatic cancer	2.38e-06	3.05e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.37e-06	3.04e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—pancreatic cancer	2.36e-06	3.03e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.35e-06	3.01e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.34e-06	3.01e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—pancreatic cancer	2.34e-06	3e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—pancreatic cancer	2.32e-06	2.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.29e-06	2.94e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—pancreatic cancer	2.29e-06	2.94e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.29e-06	2.94e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—pancreatic cancer	2.28e-06	2.93e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.27e-06	2.91e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—pancreatic cancer	2.25e-06	2.89e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—pancreatic cancer	2.23e-06	2.86e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	2.23e-06	2.86e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.18e-06	2.8e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—pancreatic cancer	2.16e-06	2.77e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.16e-06	2.77e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.14e-06	2.74e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—pancreatic cancer	2.1e-06	2.69e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—pancreatic cancer	2.05e-06	2.63e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.04e-06	2.62e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.04e-06	2.62e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.02e-06	2.6e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—pancreatic cancer	2.02e-06	2.59e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.99e-06	2.56e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.98e-06	2.54e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.98e-06	2.54e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—pancreatic cancer	1.89e-06	2.43e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.88e-06	2.41e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.86e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.86e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.85e-06	2.37e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—pancreatic cancer	1.84e-06	2.36e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—pancreatic cancer	1.82e-06	2.34e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—APOE—pancreatic cancer	1.78e-06	2.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.77e-06	2.27e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—pancreatic cancer	1.72e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—pancreatic cancer	1.71e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—pancreatic cancer	1.67e-06	2.15e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—pancreatic cancer	1.67e-06	2.14e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	1.65e-06	2.12e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.62e-06	2.08e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.61e-06	2.07e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.61e-06	2.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.61e-06	2.07e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.6e-06	2.06e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.55e-06	1.99e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.52e-06	1.95e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.41e-06	1.81e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—pancreatic cancer	1.4e-06	1.8e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.4e-06	1.79e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.35e-06	1.73e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.32e-06	1.69e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.32e-06	1.69e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.25e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.24e-06	1.6e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.23e-06	1.58e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.22e-06	1.56e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.22e-06	1.56e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.15e-06	1.47e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.14e-06	1.46e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.14e-06	1.46e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.06e-06	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.02e-06	1.31e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—pancreatic cancer	9.93e-07	1.27e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—pancreatic cancer	9.36e-07	1.2e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—pancreatic cancer	9.28e-07	1.19e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.49e-07	9.62e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.12e-07	7.85e-06	CbGpPWpGaD
